myo-inositol oxygenase:: molecular cloning and expression of a unique enzyme that oxidizes myo-inositol and D-chiro-inositol

被引:73
作者
Arner, RJ
Prabhu, KS
Thompson, JT
Hildenbrandt, GR
Liken, AD
Reddy, CC
机构
[1] Penn State Univ, Dept Vet Sci, University Pk, PA 16802 USA
[2] Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA
关键词
diabetes; D-glucuronate; kidney; mono-oxygenase; pig;
D O I
10.1042/bj3600313
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
myo-Inositol oxygenase (MIOX) catalyses the first committed step in the only pathway of myo-inositol catabolism, which occurs predominantly in the kidney. The enzyme is a non-haem-iron enzyme that catalyses the ring cleavage of myo-inositol with the incorporation of a single atom of oxygen. A full-length cDNA was isolated from a pig kidney library with an open reading frame of 849 bp and a corresponding protein subunit molecular mass of 32.7 kDa. The cDNA was expressed in a bacterial pET expression system and an active recombinant MIOX was purified from bacterial lysates to electrophoretic homogeneity. The purified enzyme displayed the same catalytic properties as the native enzyme with K-m and k(cat) values of 5.9 mM and 11 min(-1) respectively. The pI was estimated to be 4.5. Preincubation with 1 mM Fe2+ and 2 mM cysteine was essential for the enzyme's activity. D-chiro-Inositol, a myo-inositol isomer, is a substrate for the recombinant MIOX with an estimated K-m of 33.5 mM. Both myo-inositol and D-chiro-inositol have been implicated in the pathogenesis of diabetes. Thus an understanding of the regulation of MIOX expression clearly represents a potential window on the aetiology of diabetes as well as on the control of various intracellular phosphoinositides and key signalling pathways.
引用
收藏
页码:313 / 320
页数:8
相关论文
共 40 条
[1]   ALDOSE REDUCTASE INHIBITORS AND LATE COMPLICATIONS OF DIABETES [J].
BENFIELD, P .
DRUGS, 1986, 32 :43-55
[2]  
BRY K, 1991, BIOL NEONATE, V60, P249
[3]  
CHARALAMPOUS FC, 1957, J BIOL CHEM, V228, P1
[4]  
CHARALAMPOUS FC, 1959, J BIOL CHEM, V234, P220
[5]  
CHARALAMPOUS FC, 1960, J BIOL CHEM, V5, P1286
[6]  
COHEN AM, 1995, DIABETOLOGIA, V38, P899
[7]   ALDOSE REDUCTASE, GLOMERULAR METABOLISM, AND DIABETIC NEPHROPATHY [J].
COHEN, MP .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1986, 35 (04) :55-59
[8]   KINETIC MECHANISM OF SHEEP LIVER NADPH-DEPENDENT ALDEHYDE REDUCTASE [J].
DEJONGH, KS ;
SCHOFIELD, PJ ;
EDWARDS, MR .
BIOCHEMICAL JOURNAL, 1987, 242 (01) :143-150
[9]   NERVE GLUCOSE, SORBITOL, FRUCTOSE, AND MYOINOSITOL AT VARIOUS TIMES AFTER FEEDING IN STREPTOZOTOCIN-INDUCED DIABETES IN RATS [J].
DYCK, PJ ;
MINNERATH, SR ;
OBRIEN, PC .
MAYO CLINIC PROCEEDINGS, 1989, 64 (08) :905-910
[10]   Antihyperglycemic effects of 3-O-methyl-D-chiro-inositol and D-chiro-inositol associated with manganese in streptozotocin diabetic rats [J].
Fonteles, MC ;
Almeida, MQ ;
Larner, J .
HORMONE AND METABOLIC RESEARCH, 2000, 32 (04) :129-132